Global Sepsis Diagnostics Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13710977

Publishing Date : 22-Jul-2019

No. of pages : 109

PRICE
3900
7800


  • Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
    Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
    North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.
    In 2018, the global Sepsis Diagnostics market size was 290 million US$ and it is expected to reach 610 million US$ by the end of 2025, with a CAGR of 9.6% during 2019-2025.

    This report focuses on the global Sepsis Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sepsis Diagnostics development in United States, Europe and China.

    The key players covered in this study
    Biomerieux
    T2 Biosystems
    Luminex
    Becton, Dickinson
    Roche
    Danaher
    Thermo Fisher
    Bruker
    Abbott
    Immunexpress
    Response Biomedical
    Axis-Shield Diagnostics
    Cytosorbents
    Mitsubishi Chemical
    EKF Diagnostics

    Market segment by Type, the product can be split into
    Microbiology
    Molecular Diagnostics
    Immunoassays
    Flow Cytometry
    Microfluidics
    Biomarkers

    Market segment by Application, split into
    Hospitals
    Pathology & Reference Laboratories

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Sepsis Diagnostics status, future forecast, growth opportunity, key market and key players.
    To present the Sepsis Diagnostics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Sepsis Diagnostics are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports